ATNF
180 Life Sciences Corp. (ATNF)
$
36About 180 Life Sciences Corp. (ATNF)
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Details
Daily high
$1.39
Daily low
$1.32
Price at open
$1.37
52 Week High
$11.21
52 Week Low
$1.16
Market cap
727,200
Dividend yield
0.00%
Volume
16,974
Avg. volume
64,677
P/E ratio
-.05
180 Life Sciences Corp. News
Details
Daily high
$1.39
Daily low
$1.32
Price at open
$1.37
52 Week High
$11.21
52 Week Low
$1.16
Market cap
727,200
Dividend yield
0.00%
Volume
16,974
Avg. volume
64,677
P/E ratio
-.05